Stephens & Co. analyst Joshua Long reiterates McDonald’s (NYSE:MCD) with a Overweight and maintains $280 price target.
Tempus Announces Research Collaboration With Bristol Myers Squibb To Apply Multimodal AI Approaches
Tempus, a leader in artificial intelligence and precision medicine, today announced a multi-year, strategic research collaboration with Bristol Myers Squibb (NYSE:BMY). The two companies will work together to identify